Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

STOCK MARKETS - THE WEEK IN VIEW

Saturday 22 February 1997 19:02 EST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

UK shares are expected to rise this week, with exporters such as Glaxo benefiting from dollar strength.

The gains are likely to send the FT-SE 100 Index back into record territory - provided earnings from National Westminster Bank, EMI Group, Standard Chartered, Prudential, Abbey National and British Aerospace don't disappoint.

"The market will really focus on the financial results," said Job Curtis, a fund manager at Henderson Investment Management. "If they come out with reasonable results, it could be quite positive."

Exporters, whose goods become less competitive when the pound is strong, should be boosted by the currency's recent weakening. Sterling closed on Friday little changed against the dollar but comfortably below the highs seen two weeks ago.

UK drug shares could also rise this week as the US Food and Drug Administration's Cardiovascular and Renal Drugs Advisory Committee meets to review new heart drugs, including SmithKline Beecham's Coreg, a treatment for patients suffering from congestive heart failure.

The weaker pound probably won't help oil companies like British Petroleum and Shell. Crude oil prices fell to a six-month low on Friday.

It will also be a heavy earnings week in Paris, with drug company Sanofi, oil giant Elf Aquitaine, financial services group Paribas and electrical accessories maker Legrand all reporting 1996 results. Low interest rates should support the market.

In Frankfurt, shares of automakers, chemical companies and other exporters could rise this week lifted by the dollar's strength against the mark. Comments from a Bundesbank official suggesting Germany may not meet the criteria to participate in the single currency could be good news for bonds and financial shares.

In Tokyo, Japanese stocks could extend last week's gains amid optimism that the country's banks will get government help to clean up their bad debt.

In New York a Goldman, Sachs report predicted that the Standard & Poor's 500 Index may rise to 850, almost 6 per cent higher than Friday's closing price, by March next year. Copyright: IOS & Bloomberg

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in